Format

Send to

Choose Destination
Drug Resist Updat. 1999 Aug;2(4):259-269.

Drug resistance in Cryptococcus neoformans.

Author information

1
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, USA

Abstract

Cryptococcus neoformans has become a major opportunistic fungal pathogen worldwide. Successful treatment of invasive disease with this fungus has used amphotericin B, flucytosine and various azoles. However, treatment failures continue to occur for a variety of reasons including direct antifungal drug resistance. Issues and mechanisms for antifungal drug resistance in Cryptococcus neoformans are reviewed. Furthermore, approaches and strategies for prevention and treatment of antifungal drug resistance are identified and these include host immune modulation, dose optimization, prophylaxis/empirical regimens, improved drug delivery systems such as lipid preparations of amphotericin B, surgery, combination antifungal treatments and development of new antifungal agents.

PMID:
11504497
DOI:
10.1054/drup.1999.0090

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center